Funds and ETFs Dr. Reddy's Laboratories Limited

Equities

DRREDDY

INE089A01023

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:50 2024-04-26 am EDT 5-day change 1st Jan Change
6,253 INR +0.58% Intraday chart for Dr. Reddy's Laboratories Limited +5.23% +7.85%

ETFs positioned on Dr. Reddy's Laboratories Limited

Name Weight AuM 1st Jan change Investor Rating
1.02% 6 M€ +6.07% -
0.33% 1 M€ +3.49% -
0.33% 3 M€ -.--% -
0.20% 11 M€ +1.79%
0.12% 2,808 M€ +5.90% -
0.12% 441 M€ +4.60% -
0.12% 149 M€ +2.17% -
0.10% 4 M€ -4.41% -
0.05% 117 M€ +1.11% -
0.05% 0 M€ 0.00% -
0.04% 31 M€ +3.50% -
0.03% 7 M€ +1.95% -
0.03% 7 M€ +26.90% -
0.02% 15 M€ +11.24%
0.01% 34 M€ +6.71% -
0.01% 389 M€ +6.83% -
0.01% 39 M€ +3.67% -
0.01% 302 M€ +3.80% -
0.01% 34 M€ +2.14% -
0.01% 108 M€ +2.03% -
0.01% 17 M€ +1.44% -
0.01% 52 M€ -0.60% -
0.01% 16 M€ -8.49%
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows: - sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines; - sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services; - other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc. Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
6,253 INR
Average target price
6,005 INR
Spread / Average Target
-3.97%
Consensus
  1. Stock Market
  2. Equities
  3. DRREDDY Stock
  4. Funds and ETFs Dr. Reddy's Laboratories Limited